Unveiling Drug‐Induced Autoimmune‐Like Hepatitis in Autoimmune Hepatitis Patients: A Multicenter Retrospective Study
Alimentary Pharmacology & Therapeutics · 2026
DOI: 10.1111/apt.70353 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Alimentary Pharmacology & Therapeutics, 2026. Verfasst von Pinelopi Arvaniti und 28 weiteren Autor:innen. Beteiligte Einrichtung: Liver Unit, Hospital Clinic of Barcelona, Institute of Biomedical Investigations August Pi and Sunyer (IDIBAPS), CIBERehd, University of Barcelona, B…. Hauptthemen laut MEDLINE: Hepatitis, Autoimmune, Chemical and Drug Induced Liver Injury, Dietary Supplements. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 28 Literaturangaben.
Abstract (Originalsprache)
Background and Aims Acute or chronic exposure to drugs or herbal and dietary supplements (HDS) can cause drug‐induced autoimmune‐like hepatitis (DI‐ALH), a self‐limiting condition resembling autoimmune hepatitis (AIH). We investigated the prevalence of drug exposure among AIH patients at diagnosis to recognise cases of DI‐ALH and discern features predicting AIH development.
Methods
We retrospectively included 705 patients diagnosed with AIH. DI‐ALH was defined using published criteria. The clinical, biochemical, serological, and histological data of DI‐ALH and AIH were analysed to identify predictors of the evolution of each phenotype.
Results
Most patients were female ( n = 496, 70%), with a median age of 57 years and a median follow‐up of 55 months. A 59% ( n = 417) reported exposure to drugs or HDS, and 8% ( n = 58) fulfilled the criteria for DI‐ALH. Statins and HDS were the most common culprits. Patients with DI‐ALH more frequently had acute severe or fulminant hepatitis (22% vs. 12%, p = 0.013) and higher transaminase levels (ALT: 966 vs. 591, p = 0.001) at diagnosis. In total, 97% of the patients received immunosuppression. DI‐ALH patients had a faster biochemical response than i‐AIH patients (4 vs. 5, p = 0.031), while treatment withdrawal was attempted in only 29% ( n = 17). Approximately 30% ( n = 17) of DI‐ALH cases presented a flare during follow‐up. Neither clinical, histological, nor serological findings nor RUCAM and RECAM could predict a DI‐ALH flare.
Conclusions
DI‐ALH is often under‐recognised in clinical practice, leading to unnecessary long‐term immunosuppression. A causal relationship between drugs and AIH, along with an attempt to withdraw treatment and long‐term follow‐up, is essential to prevent overtreatment‐associated risks.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Liver Unit, Hospital Clinic of Barcelona, Institute of Biomedical Investigations August Pi and Sunyer (IDIBAPS), CIBERehd, University of Barcelona, Barcelona, Spain.
- Liver Unit, Department of Internal Medicine, University Hospital Vall de Hebron, Barcelona, Spain.
- CIBERehd, ERN RARE-LIVER, Barcelona, Spain.
- Complexo Hospitalario Universitario de Pontevedra, Instituto de Investigación Sanitaria Galicia Sur (IISGS), Pontevedra, Spain.
- Servicio de Aparato Digestivo, Hospital Universitario Mutua de Terrassa, Terrassa, Spain.
- Sección de Hepatología, Servicio de Aparato Digestivo, Hospital General Universitario Gregorio Marañón, CIBERehd, Madrid, Spain.
ORCID-Profile: Pinelopi Arvaniti, Mar Riveiro-Barciela, Diana Horta, Xavier Forns, Raul J Andrade
Zitieren
APA
Arvaniti, P., Olivas, I., Pascual-Dapena, A., Riveiro-Barciela, M., Esteban, P., Aguilar, A., Pérez-Medrano, I., Horta, D., Caballero Marcos, A., Salcedo, M., Conde, I., Gómez, E., Castelló, I., Bárbara, J. S., Díaz-González, Á., Del Barrio, M., Lorente, S., Mateos, B., Arencibia, A., …, & Londoño, M. C. (2026). Unveiling Drug‐Induced Autoimmune‐Like Hepatitis in Autoimmune Hepatitis Patients: A Multicenter Retrospective Study. Alimentary Pharmacology & Therapeutics. https://doi.org/10.1111/apt.70353
Vancouver
Arvaniti P, Olivas I, Pascual-Dapena A, Riveiro-Barciela M, Esteban P, Aguilar A, et al. Unveiling Drug‐Induced Autoimmune‐Like Hepatitis in Autoimmune Hepatitis Patients: A Multicenter Retrospective Study. Alimentary Pharmacology & Therapeutics. 2026. doi:10.1111/apt.70353
BibTeX
@article{Arvaniti2026,
author = {Arvaniti, Pinelopi and Olivas, Ignasi and Pascual-Dapena, Ana and Riveiro-Barciela, Mar and Esteban, Paula and Aguilar, Anna and Pérez-Medrano, Indhira and Horta, Diana and Caballero Marcos, Arancha and Salcedo, Magdalena and Conde, Isabel and Gómez, Elena and Castelló, Inmaculada and Bárbara, Jesús Santa and Díaz-González, Álvaro and Del Barrio, Maria and Lorente, Sara and Mateos, Beatriz and Arencibia, Ana and Jiménez, Miguel and Cuenca, Paqui and Bernal-Monterde, Vanesa and Fernández, Eva-Maria and Rodríguez-Tajes, Sergio and Pocurull, Anna and Hernández-Évole, Helena and Forns, Xavier and Andrade, Raul J and Londoño, Maria-Carlota},
title = {Unveiling Drug‐Induced Autoimmune‐Like Hepatitis in Autoimmune Hepatitis Patients: A Multicenter Retrospective Study},
journal = {Alimentary Pharmacology & Therapeutics},
year = {2026},
doi = {10.1111/apt.70353}
}
EUVIMED